Catherine Coste does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOMERICA INC, MINERVA SURGICAL INC, Renalytix plc, and BIOLIFE SOLUTIONS INC.

2023 was Catherine Coste's most active year for acquiring shares with 5 total transactions. Catherine Coste's most active month to acquire stocks was the month of November. 2022 saw Catherine Coste paying a total of $119,998.72 for 49,792 shares, this is the most they've acquired in one year.